TA-8995
TA-8995 is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Preliminary Drug Drug Interaction Study With TA-8995
ADME Study in Healthy Male Subjects With TA-8995
Bioequivalence Study of Capsule and Tablet Formulations of TA-8995
A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)
Study of the Electrocardiographic Effects of TA-8995
Clinical Trials (8)
A Preliminary Drug Drug Interaction Study With TA-8995
ADME Study in Healthy Male Subjects With TA-8995
Bioequivalence Study of Capsule and Tablet Formulations of TA-8995
A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)
Study of the Electrocardiographic Effects of TA-8995
TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8